Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Email
Facebook
Tweet
Print
Alvaro Ayala, MD (he/him/his)
Resident
University of Connecticut
Poster(s):
(1562) Renal Outcomes after Switch from Oral Antiretroviral therapy (ART) to Long-acting injectable Cabotegravir/Rilpivirine (LAI CAB)
Friday, October 13, 2023
12:15 PM – 1:30 PM
US ET
(1588) Weight Change among People Living with HIV who switch from Oral Antiviral Therapy to Long Acting Injectable Cabotegravir/Rilpivirine in a University-Based Clinic
Friday, October 13, 2023
12:15 PM – 1:30 PM
US ET
Email Alvaro
